Nevertheless, we did observe an increase in A2AR expression within CD8+ T cells isolated from the draining lymph nodes of mice undergoing immune checkpoint blockade, highlighting the potential for A2AR blockade to enhance T cell priming in tertiary lymphoid structures beyond the tumor microenvironment in the context of immunotherapy. This evidence concerns the gene ADORA2A and neoplasm.